| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-11 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.24 | 5e-11 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-10 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-10 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-09 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-08 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.19 | 3e-08 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.19 | 2e-07 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-07 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-07 |